These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 18034643)

  • 1. Recent findings into the potential of gene therapy to reverse heart failure.
    Pleger ST; Most P; Koch WJ
    Expert Opin Biol Ther; 2007 Dec; 7(12):1781-4. PubMed ID: 18034643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting myocardial beta-adrenergic receptor signaling and calcium cycling for heart failure gene therapy.
    Pleger ST; Boucher M; Most P; Koch WJ
    J Card Fail; 2007 Jun; 13(5):401-14. PubMed ID: 17602988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting GRK2 by gene therapy for heart failure: benefits above β-blockade.
    Reinkober J; Tscheschner H; Pleger ST; Most P; Katus HA; Koch WJ; Raake PW
    Gene Ther; 2012 Jun; 19(6):686-93. PubMed ID: 22336718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GRK2 as a novel gene therapy target in heart failure.
    Rengo G; Lymperopoulos A; Leosco D; Koch WJ
    J Mol Cell Cardiol; 2011 May; 50(5):785-92. PubMed ID: 20800067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic editing of dysfunctional myocardium.
    Hajjar RJ; Huq F; Matsui T; Rosenzweig A
    Med Clin North Am; 2003 Mar; 87(2):553-67. PubMed ID: 12693739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy targets in heart failure: the path to translation.
    Raake PW; Tscheschner H; Reinkober J; Ritterhoff J; Katus HA; Koch WJ; Most P
    Clin Pharmacol Ther; 2011 Oct; 90(4):542-53. PubMed ID: 21866097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cellular and physiologic effects of beta blockers in heart failure.
    Sabbah HN
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic manipulation of beta-adrenergic signalling in heart failure.
    Davidson MJ; Koch WJ
    Acta Physiol Scand; 2001 Sep; 173(1):145-50. PubMed ID: 11678737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy to restore electrophysiological function in heart failure.
    Motloch LJ; Akar FG
    Expert Opin Biol Ther; 2015 Jun; 15(6):803-17. PubMed ID: 25865107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model-specific selection of molecular targets for heart failure gene therapy.
    Katz MG; Fargnoli AS; Tomasulo CE; Pritchette LA; Bridges CR
    J Gene Med; 2011 Oct; 13(10):573-86. PubMed ID: 21954055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for heart failure.
    Thompson RB; Rungwerth K; Koch WJ
    Ann Med; 2004; 36 Suppl 1():106-15. PubMed ID: 15176432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in gene therapy for heart failure.
    Fish KM; Ishikawa K
    Discov Med; 2015 Apr; 19(105):285-91. PubMed ID: 25977191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac resynchronization therapy restores sympathovagal balance in the failing heart by differential remodeling of cholinergic signaling.
    DeMazumder D; Kass DA; O'Rourke B; Tomaselli GF
    Circ Res; 2015 May; 116(10):1691-9. PubMed ID: 25733594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue.
    Pleger ST; Most P; Boucher M; Soltys S; Chuprun JK; Pleger W; Gao E; Dasgupta A; Rengo G; Remppis A; Katus HA; Eckhart AD; Rabinowitz JE; Koch WJ
    Circulation; 2007 May; 115(19):2506-15. PubMed ID: 17470693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100A1 gene therapy for heart failure: a novel strategy on the verge of clinical trials.
    Rohde D; Brinks H; Ritterhoff J; Qui G; Ren S; Most P
    J Mol Cell Cardiol; 2011 May; 50(5):777-84. PubMed ID: 20732326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac adenoviral S100A1 gene delivery rescues failing myocardium.
    Most P; Pleger ST; Völkers M; Heidt B; Boerries M; Weichenhan D; Löffler E; Janssen PM; Eckhart AD; Martini J; Williams ML; Katus HA; Remppis A; Koch WJ
    J Clin Invest; 2004 Dec; 114(11):1550-63. PubMed ID: 15578088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Therapy in Heart Failure.
    Fargnoli AS; Katz MG; Bridges CR; Hajjar RJ
    Handb Exp Pharmacol; 2017; 243():395-421. PubMed ID: 27796512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene interventions in the beta-adrenergic system for treating heart failure.
    Parsa CJ; Koch WJ
    Semin Thorac Cardiovasc Surg; 2003 Jul; 15(3):259-67. PubMed ID: 12973703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential future therapies for heart failure: gene transfer of beta-adrenergic signaling components.
    Maurice JP; Koch WJ
    Coron Artery Dis; 1999 Sep; 10(6):401-5. PubMed ID: 10474791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging strategies for chronic heart failure: the role of gene therapy.
    Milano EG; Cicoira M
    Rev Cardiovasc Med; 2012; 13(4):e161-8. PubMed ID: 23470684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.